Education. Evidence. Regrowth.
Prioritize knowledge. Make better choices.
Sort good studies from the bad.
Get bigger hair gains.
PhD's, resarchers, & consumer advocates.
Founder, researcher, & consumer advocate
Our team of PhD’s, researchers, & more
Discover how we conduct our research.
Have questions? Contact us.
Our library of before-after photos.
I have attached my before and afters of my progress since joining this group...
I’m convinced I’ve recovered to probably the hairline I had 3 years ago. Super stoked…
My friends actually told me, “Your hairline improved. Your hair looks thicker...
I also feel my hair has a different texture to it now…
Firstly thank you for your work in this field. I am immensely grateful that...
I just wanted to thank you for all your research, for introducing me to this method...
To be honest I am having fun with all this and I still don’t know how much...
I see a massive amount of regrowth that is all less than about 8 cm long...
150+ member experiences.
Popular treatments. But do they work?
Top-selling ingredients, quantified.
The truth about hair loss "best sellers".
Xyon Health
Strut Health
Happy Head
DS Laboratories
Advanced Trichology
Fully Vital
Xyon Health
DrFormulas
Revivogen MD
Standardized rubrics to evaluate all treatments.
Is this treatment well studied?
How much regrowth can you expect?
Is this treatment safe & sustainable?
Apps, tools, guides, freebies, & more.
100+ free articles.
Our team’s peer-reviewed studies.
Education. Evidence. Regrowth.
PhD's, resarchers, & consumer advocates.
Discover how we conduct our research.
Have questions? Contact us.
Our library of before-after photos.
Read the experiences of members
Get personalized support, product recommendations, video calls, and more from our researchers, trichologists, and PhD's dedicated to getting you the best possible outcomes.
Learn MoreOnline discussions have raised alarms about a possible link between minoxidil and premature skin aging, especially among users reporting under-eye puffiness, dryness, and fine lines. Could a hair loss treatment really be affecting facial skin quality? This article takes a balanced look at the science and speculation. It explores the proposed biological mechanisms, like prostaglandin changes and collagen disruption, and considers alternative explanations such as allergic reactions or water retention. You can also find tips on how to prevent or mitigate potential skin-related side effects when using topical or oral minoxidil.
Minoxidil was originally developed in the 1970s as an oral medication for the treatment of hypertension (high blood pressure). This was due to its key function as a vasodilator, widening the blood vessels and, in turn, increasing blood flow and reducing blood pressure. However, an unintended side effect quickly became apparent in nearly all use cases: excessive hair growth.
Seeking to take advantage of this, minoxidil was re-formulated as a topical solution for the treatment of hair loss. After showing great efficacy in clinical trials of patients with androgenetic alopecia (AGA), topical minoxidil [5%] received FDA approval for the treatment of male pattern hair loss in 1988, with a lower dose of topical minoxidil [2%] later being approved for the treatment of female pattern hair loss. And, while it is not technically an FDA-approved treatment, oral minoxidil is also used off-label to treat hair loss.[1]Suchonwanit, P., Thammarucha, S., & Leerunyakul, K. (2019). Minoxidil and its use in hair disorders: a review. Drug design, development and therapy. 2777-2786. Available at: … Continue reading
Given that this application of minoxidil was first identified as an unintended side effect, it is unsurprising that the use of both topical and oral minoxidil can lead to other unwanted effects. In a previous article, we discussed the most common and widely recognized side effects of minoxidil use. Here, however, we will explore a potential side effect that has been reported by some minoxidil users: accelerated skin aging.
Is it possible that minoxidil can accelerate skin aging? In this article, we’ll review the current landscape of research and dive into the anecdotes, the biological mechanisms, alternative explanations, and where we currently stand on this topic.
Skin aging is a multifactorial biological process that is mediated by intrinsic (genetically determined) and extrinsic (environmental) factors. Natural, intrinsic aging occurs over a long time, with a gradual decrease in skin structure and function leading to the formation of fine lines, wrinkles, thinning, dryness, and reduced elasticity. This is compounded by the extrinsic factors, such as ultraviolet radiation and pollution, which can cause wrinkles that are more coarse, more severe loss of elasticity, and pigmentation disorders.[2]Shin, S. H., Lee, Y. H., Rho, N. K., & Park, K. Y. (2023). Skin aging from mechanisms to interventions: focusing on dermal aging. Frontiers in physiology. 14. 1195272. Available at: … Continue reading
There are several key mechanisms that underlie these factors, including:
As stated, intrinsic factors and genetics means that these mechanisms will naturally cause skin health to deteriorate as we get older. However, we also know that certain environmental factors can accelerate the aging process by promoting the activity of the described mechanisms. It is therefore possible that a therapy that acts upon these mechanisms could influence the aging process.
On reddit, some people using topical minoxidil have reported what sounds like accelerated aging: that their under-eye bags worsened and that their facial skin seemed drier and less smooth than before. Others have documented these changes with before-and-after photos taken just 1-2 months after starting the topical medication. Similar anecdotes have been reported by some users of oral minoxidil. This has led to claims that minoxidil use may accelerate skin aging.
But do these anecdotes make sense biologically? And are these reports truly suggestive of faster skin aging, or is something else going on?
Let’s take a look at what the scientific evidence says.
There is a lack of understanding regarding the specific underlying mechanism by which minoxidil promotes hair growth. Indeed, several different mechanisms have been suggested, and it is believed that more than one may be responsible for mediating the effects of minoxidil. In the context of aging skin, one of these mechanisms is particularly interesting: the minoxidil-induced increase in prostaglandin E2 (PGE2) production.
Back in 1997, researchers discovered that minoxidil significantly increased the production of PGE2 in murine fibroblast cells in vitro. Moreover, they showed that minoxidil also increased the production of PGE2 in human dermal papilla fibroblasts, cells that sit within the base of the hair follicle and play an important role in maintaining hair health.[6]Michelet, J. F., Commo, S., Billoni, N., Mahé, Y. F., & Bernard, B. A. (1997). Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair … Continue reading Later, in mice, it was also demonstrated that the topical application of PGE2 exhibited some, albeit limited, ability to promote hair growth. [7]Sasaki, S., Hozumi, Y., & Kondo, S. (2005). Influence of prostaglandin F2α and its analogues on hair regrowth and follicular melanogenesis in a murine model. Experimental dermatology. 14(5). … Continue reading
Figure 1: Minoxidil increases the production of PGE2 in vitro. Treatment with minoxidil increased PGE2 levels in cultured human dermal papilla fibroblasts (a) and murine fibroblasts (b).[8]Michelet, J. F., Commo, S., Billoni, N., Mahé, Y. F., & Bernard, B. A. (1997). Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair … Continue reading
So PGE2 may be part of a mechanism that minoxidil uses to promote hair growth, but what does that have to do with skin aging?
One study found that PGE2 levels in the skin increase with age, with fibroblasts being the main source of increased production. When the same researchers cultured fibroblasts with PGE2 in vitro, they also demonstrated that PGE2 treatment causes a reduction in the expression of type I procollagen.[9]Li, Y., Lei, D., Swindell, W.R., Xia, W., Weng, S., Fu, J., Worthen, C.A., Okubo, T., Johnston, A., Gudjonsson, J.E. and Voorhees, J.J. 2015. Age-associated increase in skin fibroblast–derived … Continue reading
Figure 2: PGE2 levels in the skin. Aged populations exhibit increased levels of PGE2 within their skin that younger populations.[10]Li, Y., Lei, D., Swindell, W.R., Xia, W., Weng, S., Fu, J., Worthen, C.A., Okubo, T., Johnston, A., Gudjonsson, J.E. and Voorhees, J.J. 2015. Age-associated increase in skin fibroblast–derived … Continue reading
Additional studies have provided further evidence that PGE2 impairs collagen homeostasis within the skin. In cultured human dermal fibroblasts, it was shown that treatment with PGE2 significantly decreased collagen type I levels, which may have been driven by the significant increase in matrix metallopeptidase 1 (MMP1) levels.[11]Shim, J. H. (2019). Prostaglandin E2 induces skin aging via E-prostanoid 1 in normal human dermal fibroblasts. International Journal of Molecular Sciences, 20(22), 5555. Available at: … Continue reading Thus, there exists a wealth of evidence which suggests that PGE2 plays a role in the aging of skin by impairing collagen homeostasis.
Given that minoxidil has been shown to increase PGE2, and that PGE2 is associated with aging skin, does this mean that minoxidil use leads to accelerated aging of the skin?
Not necessarily.
Firstly, and most crucially, there are currently no studies that have shown a direct link between the use of minoxidil and accelerated skin aging. Until such research is conducted, it is not possible to draw an accurate conclusion.
Now, in general, with safety concerns — it’s usually important to emphasize that the absence of evidence does not mean evidence against a concept. For instance, just because we don’t have a randomized, controlled clinical study determining the likelihood of death from jumping out of an airplane without a parachute, the risk here is inherently obvious: we don’t need a study to prove death is likely. We can just look at surrogate data on max velocity, the heights of falls, and the human capacity to endure such a violent impact. And then we can presume death is the most likely outcome.
So, can we use surrogate data on minoxidil — such as these in vitro studies — and then can we associate these to skin thinning, pair those with the anecdotal reports from Reddit, and presume that topical minoxidil is accelerating skin aging in some people, regardless of what the clinical studies say?
You could. But given that this side effect wasn’t picked up in any of the large, randomized, controlled clinical trials on minoxidil prior to these internet posts, our opinion is that we should exercise extreme caution in coming to this conclusion. Why? Because beyond the absence of clinical data on minoxidil doing this in well-designed studies, there are also two side effects of minoxidil application that might be fully-to-blame for why some think minoxidil use accelerates skin aging. And encouragingly, these side effects aren’t permanent:
We’ll take these one-by-one.
Minoxidil is able to function as a vasodilator by opening potassium channels, thus relaxing the vascular smooth muscle and lowering blood pressure. However, this modification of potassium channels also increases sodium reabsorption by the kidneys which, in turn, leads to greater retention of water by the body.[12]Sica, D. A. (2004). Minoxidil: an underused vasodilator for resistant or severe hypertension. The Journal of Clinical Hypertension. 6(5). 283-287. Available at: … Continue reading
Water retention can lead to edema (swelling) and, although this is typically seen in peripheral regions such as the feet, use of oral minoxidil (even at low doses) has been found to cause facial edema in up to 1% of use cases.[13]Sanabria, B., de Nardo Vanzela, T., Miot, H. A., & Ramos, P. M. (2021). Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients. Journal of the American Academy of … Continue reading Indeed, a recent study demonstrated a dose-dependent relationship between oral minoxidil and the incidence of edema.[14]Salas, J., Esse, I., Kincaid, C. M., Birda, A., Choe, S., & Mesinkovska, N. A. (2025). Characterizing low-dose oral minoxidil-induced peripheral edema in alopecia patients. Journal of the … Continue reading Some users of topical minoxidil have also reported swelling around the face after use, particularly in the region surrounding their eyes.
A consequence of facial edema is a more plump appearance of the face and potentially sagging of the skin, which can also accentuate under-eye bags and make it appear as though someone is less rested than they actually are. These symptoms mimic those of aging skin and they can make it seem like minoxidil is accelerating the aging process. However, the same studies that observed the cases of facial edema also noted that the swelling typically resolved within two weeks of stopping treatment, so it is unlikely that these effects are truly reflective of accelerated skin aging.
Another side effect of minoxidil use, particularly when it is applied topically, is allergic dermatitis. At the site of application, symptoms of allergic dermatitis such as itching, redness, and scaling, were observed in 5.7% of topical minoxidil [5%] users.[15]Friedman, E. S., Friedman, P. M., Cohen, D. E., & Washenik, K. (2002). Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. Journal of the American Academy of … Continue reading
Figure 3: Allergic dermatitis in a minoxidil user. Patch testing with minoxidil [1%] in isopropanol revealed a positive allergic contact reaction.[16]Friedman, E. S., Friedman, P. M., Cohen, D. E., & Washenik, K. (2002). Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. Journal of the American Academy of … Continue reading
Whether the allergen is minoxidil, propylene glycol, or another ingredient, it is clear that topical minoxidil has the potential to cause allergic dermatitis. Of course, the relevance of this is that the symptoms associated with allergic dermatitis may mimic signs of aging skin, once again leading users to believe that minoxidil is causing accelerated skin aging. However, as observed with water retention, it has been shown that the symptoms of contact dermatitis stop after ceasing minoxidil use.[19]Pasricha, J. S., Nanda, A., & Bajaj, N. (1991). Contact dermatitis due to minoxidil. Indian Journal of Dermatology, Venereology and Leprology. 57. 235. Available at: … Continue reading
Together, these effects are probably more likely to explain the skin quality-topical minoxidil connection than true accelerated skin aging. Otherwise, the results would sustain even after quitting the medication, but there is no scientific or anecdotal evidence of this.
How can one avoid potential skin-related minoxidil side effects? There are several options at your disposal:
There is some anecdotal evidence which suggests that the use of minoxidil causes accelerated aging of the skin. Although minoxidil does drive increased production of PGE2, which is associated with reduced collagen production in the skin, there is no direct scientific evidence that has proven a link between the use of minoxidil and skin aging. Furthermore, two side effects of minoxidil use – increased water retention and allergic dermatitis – produce symptoms that mimic those of aging skin. Therefore, it is possible that temporary side effects of minoxidil use, the effects of which reverse after stopping treatment, are simply being mistaken for accelerated skin aging. Based on this, it is unlikely (though not impossible) that there is a link between minoxidil and skin aging.
References[+]
↑1 | Suchonwanit, P., Thammarucha, S., & Leerunyakul, K. (2019). Minoxidil and its use in hair disorders: a review. Drug design, development and therapy. 2777-2786. Available at: https://doi.org/10.2147/DDDT.S214907 |
---|---|
↑2 | Shin, S. H., Lee, Y. H., Rho, N. K., & Park, K. Y. (2023). Skin aging from mechanisms to interventions: focusing on dermal aging. Frontiers in physiology. 14. 1195272. Available at: https://doi.org/10.3389/fphys.2023.1195272 |
↑3 | Rinnerthaler, M., Bischof, J., Streubel, M. K., Trost, A., & Richter, K. (2015). Oxidative stress in aging human skin. Biomolecules. 5(2). 545-589. Available at: https://doi.org/10.3390/biom5020545 |
↑4 | Chin, T., Lee, X. E., Ng, P. Y., Lee, Y., & Dreesen, O. (2023). The role of cellular senescence in skin aging and age-related skin pathologies. Frontiers in physiology. 14. 1297637. Available at: https://doi.org/10.3389/fphys.2023.1297637 |
↑5 | He, X., Gao, X., & Xie, W. (2023). Research progress in skin aging, metabolism, and related products. International journal of molecular sciences. 24(21). 15930. Available at: https://doi.org/10.3390/ijms242115930 |
↑6 | Michelet, J. F., Commo, S., Billoni, N., Mahé, Y. F., & Bernard, B. A. (1997). Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect. Journal of investigative dermatology. 108(2). 205-209. Available at: https://doi.org/10.1111/1523-1747.ep12334249 |
↑7 | Sasaki, S., Hozumi, Y., & Kondo, S. (2005). Influence of prostaglandin F2α and its analogues on hair regrowth and follicular melanogenesis in a murine model. Experimental dermatology. 14(5). 323-328. Available at: https://doi.org/10.1111/j.0906-6705.2005.00270.x |
↑8 | Michelet, J. F., Commo, S., Billoni, N., Mahé, Y. F., & Bernard, B. A. (1997). Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect. Journal of investigative dermatology. 108(2). 205-209. Available at: https://doi.org/10.1111/1523-1747.ep12334249 |
↑9 | Li, Y., Lei, D., Swindell, W.R., Xia, W., Weng, S., Fu, J., Worthen, C.A., Okubo, T., Johnston, A., Gudjonsson, J.E. and Voorhees, J.J. 2015. Age-associated increase in skin fibroblast–derived prostaglandin E2 contributes to reduced collagen levels in elderly human skin. Journal of Investigative Dermatology. 135(9). 2181-2188. Available at: https://doi.org/10.1038/jid.2015.157 |
↑10 | Li, Y., Lei, D., Swindell, W.R., Xia, W., Weng, S., Fu, J., Worthen, C.A., Okubo, T., Johnston, A., Gudjonsson, J.E. and Voorhees, J.J. 2015. Age-associated increase in skin fibroblast–derived prostaglandin E2 contributes to reduced collagen levels in elderly human skin. Journal of Investigative Dermatology. 135(9). 2181-2188. Available at: https://doi.org/10.1038/jid.2015.157 |
↑11 | Shim, J. H. (2019). Prostaglandin E2 induces skin aging via E-prostanoid 1 in normal human dermal fibroblasts. International Journal of Molecular Sciences, 20(22), 5555. Available at: https://doi.org/10.3390/ijms20225555 |
↑12 | Sica, D. A. (2004). Minoxidil: an underused vasodilator for resistant or severe hypertension. The Journal of Clinical Hypertension. 6(5). 283-287. Available at: https://doi.org/10.1111/j.1524-6175.2004.03585.x |
↑13 | Sanabria, B., de Nardo Vanzela, T., Miot, H. A., & Ramos, P. M. (2021). Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients. Journal of the American Academy of Dermatology. 84(4). 1175-1178. Available at: https://doi.org/10.1016/j.jaad.2020.11.035 |
↑14 | Salas, J., Esse, I., Kincaid, C. M., Birda, A., Choe, S., & Mesinkovska, N. A. (2025). Characterizing low-dose oral minoxidil-induced peripheral edema in alopecia patients. Journal of the American Academy of Dermatology. 92(3). 632-634. Available at: https://doi.org/10.1016/j.jaad.2024.09.078 |
↑15, ↑17 | Friedman, E. S., Friedman, P. M., Cohen, D. E., & Washenik, K. (2002). Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. Journal of the American Academy of Dermatology. 46(2). 309-312. Available at: https://doi.org/10.1067/mjd.2002.119104 |
↑16 | Friedman, E. S., Friedman, P. M., Cohen, D. E., & Washenik, K. (2002). Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. Journal of the American Academy of Dermatology. 46(2). 309-312. Available at: https://doi.org/10.1067/mjd.2002.119104 |
↑18 | Junge, A., Radonjic-Hoesli, S., Bossart, S., Simon, D., De Viragh, P., Hunger, R.E., Heidemeyer, K. and Jafari, S.M.S., 2025. Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation. Acta Dermato-Venereologica. 105. 42401. Available at: https://doi.org/10.2340/actadv.v105.42401 |
↑19 | Pasricha, J. S., Nanda, A., & Bajaj, N. (1991). Contact dermatitis due to minoxidil. Indian Journal of Dermatology, Venereology and Leprology. 57. 235. Available at: https://ijdvl.com/contact-dermatitis-due-to-minoxidil/ (Accessed: 16 May 2025) |
Get personalized support, product recommendations, video calls, and more from our researchers, trichologists, and PhD's dedicated to getting you the best possible outcomes.
Learn MoreBenjamin Fletcher is a researcher & writer who holds a BSc in Biological Sciences and an MSc in Genes, Drugs & Stem Cells. Benjamin is currently pursuing a Ph.D. in Molecular Biology & Genetics, conducting research to better understand the regulatory mechanisms that drive muscle atrophy in disease, with a particular focus on the influence of microRNAs.
Get personalized support, product recommendations, video calls, and more from our researchers, trichologists, and PhD's dedicated to getting you the best possible outcomes.
Join Now